14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
PMI vs CBLL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Picard Medical, Inc. (PMI) is the stronger overall head-to-head candidate over CeriBell, Inc. (CBLL) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow). PMI carries a Unified Composite Score of 48.4/100 (HOLD) at $6.30 (N/M Forward P/E, -248.1% operating margin), whereas CBLL carries 59.7/100 (HOLD) at $25.75 (N/M Forward P/E, -69.8% operating margin).
Composite vs. Pillar Nuance: While CBLL currently prints a higher short-term Unified Composite Score (59.7/100 HOLD vs. PMI 48.4/100 HOLD), PMI captures the overall institutional head-to-head verdict (4–5 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (-248.1% vs. -69.8% operating margin) and revenue trajectory (+38.6% vs. +29.9% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PMI vs CBLL. Trailing 12-month operating profitability (PMI -248.1% vs CBLL -69.8%) and valuation multiples (PMI N/M vs CBLL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $995.3M market capitalization and -69.8% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ PMI vs CBLL Key Questions & Quantitative Answers
As of Nov 19, 2026, Picard Medical, Inc. (PMI) is the stronger overall head-to-head candidate over CeriBell, Inc. (CBLL) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow). PMI carries a Unified Composite Score of 48.4/100 (HOLD) at $6.30 (N/M Forward P/E, -248.1% operating margin), whereas CBLL carries 59.7/100 (HOLD) at $25.75 (N/M Forward P/E, -69.8% operating margin). Composite vs. Pillar Nuance: While CBLL currently prints a higher short-term Unified Composite Score (59.7/100 HOLD vs. PMI 48.4/100 HOLD), PMI captures the overall institutional head-to-head verdict (4–5 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (-248.1% vs. -69.8% operating margin) and revenue trajectory (+38.6% vs. +29.9% YoY).
CBLL leads the Growth & Scale pillar: PMI posts +38.6% YoY revenue growth and +0.0% YoY earnings growth on $6.3M TTM revenue (18.6% gross margin, -248.1% operating margin), compared with CBLL at +29.9% YoY revenue growth and +0.0% YoY earnings growth on $109M TTM revenue (89.3% gross margin, -69.8% operating margin). On trailing 12-month operating scale, PMI generates $6.3M in USD-normalized revenue versus $109M for CBLL. In operating R&D and SG&A reinvestment, PMI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CBLL.
PMI screens cheaper on headline valuation multiples. PMI trades at N/M Forward P/E, 2.9x Trailing P/E, N/M PEG, and 3.2x EV/Revenue (unreported FCF margin), whereas CBLL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.2x EV/Revenue (-68.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PMI (0.0% ROE) versus CBLL (-52.5% ROE) capital efficiency.
In options market volatility and institutional positioning, PMI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (54.06β · 134% Vol realized risk). By comparison, CBLL carries 67.5% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.08β · 41% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.